<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>09001570551306</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>semperguard sapphire XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016135</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.744Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551320</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>semperguard sapphire XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016136</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.732Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551436</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016142</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.716Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551450</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016143</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.695Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551474</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016144</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.679Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551498</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016145</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.664Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551511</udiDi>
    <basicUdiDi>9001570LCT-059NA-N-32M</basicUdiDi>
    <tradeName>semperguard latex force</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T010201</emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016174</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.640Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551535</udiDi>
    <basicUdiDi>9001570LCT-059NA-N-32M</basicUdiDi>
    <tradeName>semperguard latex force</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T010201</emdnCode>
    <emdnDescription>LATEX EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016175</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.619Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551559</udiDi>
    <basicUdiDi>9001570N*F-047OB-N-3SS</basicUdiDi>
    <tradeName>semperguard force blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016180</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.599Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551573</udiDi>
    <basicUdiDi>9001570N*F-047OB-N-3SS</basicUdiDi>
    <tradeName>semperguard force blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016181</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.578Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551597</udiDi>
    <basicUdiDi>9001570N*F-047OB-N-3SS</basicUdiDi>
    <tradeName>semperguard force blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016182</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.564Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551610</udiDi>
    <basicUdiDi>9001570N*F-047OB-N-3SS</basicUdiDi>
    <tradeName>semperguard force blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016183</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.544Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551634</udiDi>
    <basicUdiDi>9001570N*F-047OB-N-3SS</basicUdiDi>
    <tradeName>semperguard force blue</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016184</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.524Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551665</udiDi>
    <basicUdiDi>9001570N*F-047OB-S-3TK</basicUdiDi>
    <tradeName>sempermed safe sterile</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016227</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.461Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551689</udiDi>
    <basicUdiDi>9001570N*F-047OB-S-3TK</basicUdiDi>
    <tradeName>sempermed safe sterile</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016228</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.434Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551719</udiDi>
    <basicUdiDi>9001570NOF-032RB-N-32K</basicUdiDi>
    <tradeName>sempermed skySense (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016146</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.404Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551733</udiDi>
    <basicUdiDi>9001570NOF-033GR-G-332</basicUdiDi>
    <tradeName>sempermed green X-free</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016156</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.368Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551764</udiDi>
    <basicUdiDi>9001570NOF-033GR-G-332</basicUdiDi>
    <tradeName>sempermed green X-free</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016157</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.349Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551788</udiDi>
    <basicUdiDi>9001570NOF-033GR-G-332</basicUdiDi>
    <tradeName>sempermed green X-free</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016158</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.336Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570551801</udiDi>
    <basicUdiDi>9001570N*F-047OB-S-3TK</basicUdiDi>
    <tradeName>sempermed safe sterile</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000016225</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:43.316Z</lastUpdated>
  </row>
</eudamedExport>